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Summary
 
Orally administered antigens often generate immune responses that are distinct from those in-
jected systemically. The role of antigen-presenting cells in determining the type of T helper
cell response induced at mucosal versus systemic sites is unclear. Here we examine the pheno-
typic and functional differences between dendritic cells (DCs) freshly isolated from Peyer’s
patches (PP) and spleen (SP). Surface phenotypic analysis of CD11c
 
1
 
 DC populations revealed
that PP DCs expressed higher levels of major histocompatibility complex class II molecules, but
similar levels of costimulatory molecules and adhesion molecules compared with SP DCs.
Freshly isolated, flow cytometrically sorted 98–100% pure CD11c
 
1
 
 DC populations from PP
and SP were compared for their ability to stimulate naive T cells. First, PP DCs were found to
be much more potent in stimulating allogeneic T cell proliferation compared with SP DCs.
Second, by using naive T cells from ovalbumin peptide–specific T cell receptor transgenic
mice, these ex vivo DCs derived from PP, but not from SP, were found to prime for the pro-
duction of interleukin (IL)-4 and IL-10 (Th2 cytokines). In addition, PP DCs were found to
prime T cells for the production of much lower levels of interferon (IFN)-
 
g
 
 (Th1) compared
with SP DCs. The presence of neutralizing antibody against IL-10 in the priming culture dra-
matically enhanced IFN-
 
g
 
 production by T cells stimulated with PP DCs. Furthermore, stim-
ulation of freshly isolated PP DCs via the CD40 molecule resulted in secretion of high levels of
IL-10, whereas the same stimulus induced no IL-10 secretion from SP DCs. These results sug-
gest that DCs residing in different tissues are capable of inducing distinct immune responses and
that this may be related to the distinct cytokines produced by the DCs from these tissues.
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P
 
eyer’s patches (PP)
 
1
 
 represent the primary site for up-
take and presentation of ingested antigens in the intes-
tine. One of the unique features of mucosal lymphoid tissues
such as PP is their capacity to induce Th cells producing
type 2 (IL-4, IL-5, and IL-10; Th2) (1) and type 3 (TGF-
 
b
 
;
Th3) (2) cytokines. Induction of these Th cell responses is
important for the production of IgA and the generation of
regulatory cell–mediated oral tolerance, two prominent
unique features of immune responses to oral antigens. How-
ever, despite this capacity to generate Th2/Th3 responses
in PP, distinct Th1 responses can be induced in the mucosa,
particularly after intestinal infection with pathogenic micro-
organisms. For instance, IFN-
 
g
 
 secretion by PP T cells has
been observed after gastrointestinal infection with
 
 Salmo-
nella
 
 
 
typhimurium 
 
(3–6)
 
 
 
and
 
 Toxoplasma
 
 
 
gondii 
 
(7)
 
.
 
 In addi-
tion, high dose antigen feeding results in a transient Th1
response before T cell clonal deletion (8, 9).
The mechanisms that determine the ability of PP to gen-
erate Th2/Th3 responses, yet allow for the differentiation
of Th1 responses after infection with pathogenic organisms,
are not known. One possibility is that the cytokine environ-
ment in the intestinal mucosa favors the differentiation of
Th2/Th3 cells (e.g.,
 
 
 
high levels of IL-4 and TGF-
 
b
 
), but
that this pattern is overridden by strong signals from patho-
gens, such as those that directly induce IL-12 from APCs.
Another important factor may be the nature of the resident
APCs. In this regard, it has recently been suggested that
resident DCs may differ in their capacities to drive T cell
differentiation (10).
An earlier study from our laboratory identified different
populations of PP dendritic cells (DCs) by immunohis-
tochemistry. We characterized two distinct populations of
DCs in PP, namely those that reside just underneath the
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2m, 
 
b
 
2 microglobulin;
 
 
 
DC, dendritic
cell; ICAM, intracellular adhesion molecule; IFR, interfollicular T cell
regions; PCC, pigeon cytochrome 
 
c
 
; PP, Peyer’s patch(es); RT-PCR, re-
verse transcriptase PCR; SED, subepithelial dome; SP, spleen(s). 
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follicle-associated epithelium in the subepithelial dome
(SED) region of the PP, and those that are present in the
interfollicular T cell regions (IFR) (11). The SED DCs ex-
press the DC marker CD11c, but not other DC markers,
such as DEC-205 and the intracellular antigen recognized
by mAb M342. These cells are anatomically ideally situated
for taking up luminal antigens transported by M cells. On
the other hand, populations of DCs in the IFR express
CD11c as well as DEC-205 and stain with M342. The ex-
pression of DEC-205, as well as the M342 antigen, corre-
lates with DC differentiation in vitro, and these antigens are
expressed by interdigitating DCs from other lymphoid or-
gans, suggesting that the IFR DCs are more mature or dif-
ferentiated than those in the SED. In addition, these cells
are more likely responsible for priming T cells because they
come in close contact with naive T cells at this site, much
like interdigitating DCs in the spleen (SP) or peripheral
lymph node. Whether SED DCs are immature DCs that
migrate to the IFR of the PP to become IFR DCs or
whether these two subsets of DCs have entirely separate
lineages and functions in PP is unknown.
In this report, we address the issue of whether freshly
isolated DCs from PP are different from DCs from SP in
both their surface phenotype and their ability to induce T
cell differentiation. To decipher the functions of unmanip-
ulated DCs from tissues, we have opted to use an isolation
method based on selection by magnetic beads that requires
no in vitro
 
 
 
tissue culture step. Cells isolated in this manner
from SP and PP were further purified by flow cytometric
sorting to obtain 98–100% pure CD11c
 
1
 
 DCs. We show
that PP DCs express higher levels of MHC class II com-
pared with SP DCs, whereas the levels of expression of co-
stimulatory molecules CD80 and CD86 were low in both
DC populations. A similar percentage of PP DCs and SP
DCs expressed CD8
 
a
 
 and DEC-205. In functional studies,
we show that freshly isolated PP DCs are much more po-
tent stimulators of both allogeneic and antigen-specific T
cell proliferation compared with SP DCs. Moreover, using
naive OVA-specific TCR transgenic T cells, PP DCs, but
not SP DCs, primed T cells for the production of Th2 cy-
tokines. In addition, SP DCs primed T cells for the pro-
duction of much higher levels of IFN-
 
g
 
 compared with PP
DCs. Finally, stimulation of freshly isolated DCs with
CD40L trimer induced secretion of IL-10 exclusively from
those isolated from PP but not from SP.
 
Materials and Methods
 
Animals.
 
6–8-wk-old female BALB/c mice and B10.A mice
were obtained from the National Cancer Institute. Mice trans-
genic for TCR that recognize OVA323–339 peptide in the con-
text of I-A
 
d
 
 (DO11.10TCR-
 
a/b
 
 transgenic mice) on a BALB/c
background were produced as previously described (12) and were
provided by Dr. Dennis Loh (Washington University, St. Louis,
MO). Mice transgenic for TCR specific for pigeon cytochrome 
 
c
 
(PCC) 88–104 in the context of I-E
 
k
 
 on a B10.A background
crossed to RAG2
 
2/2
 
 mice were obtained from Taconic Farms, Inc.
 
Tissue Culture Media.
 
RPMI 1640 medium supplemented
 
with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, 1 mM sodium pyruvate, 3 mM 
 
l
 
-glutamine, and
50 
 
m
 
M 
 
b
 
-ME was used for primary DC–T cell coculture and
DC culture, as well as for secondary T cell stimulation culture.
 
Peptide.
 
Peptides corresponding to residues 323–339 of OVA
(ISQAVHAAHAEINEAGR) and 88–104 of PCC (KAERADLI-
AYLKQATAK) were synthesized by the National Institute of
Allergy and Infectious Diseases Laboratory of Molecular Structure.
 
Reverse Transcriptase PCR and Competitive Reverse Transcriptase PCR.
 
Total RNA was isolated from sorted DC populations by RNA
isolation column (Qiagen), and subsequently digested with
RNase-free DNase (GIBCO BRL) to remove contaminating
genomic DNA. Single-stranded cDNA was synthesized using
SuperScript preamplification system (GIBCO BRL), and PCR
was carried out for 35 cycles using primer pairs for CD3
 
e
 
 (forward,
5
 
9
 
 CACTTTCTGGGGCATCCTGT 3
 
9
 
; reverse, 5
 
9
 
 CAGTACT-
CACACACTCGAGC 3
 
9
 
), CD19 (forward, 5
 
9
 
 TCTCTATTGT-
CAAAGAGCCT 3
 
9
 
; reverse, 5
 
9
 
 CTTCCTCTGGACCCATG-
GGC 3
 
9
 
), TGF-
 
b
 
 (forward, 5
 
9
 
 ACCGCAACAACGCCATC-
TAT 3
 
9
 
; reverse, 5
 
9
 
 GTAACGCCAGGAATTGTTGC 3
 
9
 
), and
 
b
 
2-microglobulin (
 
b
 
2m; forward, 5
 
9
 
 TGACCGGCTTGTAT-
GCTATC 3
 
9
 
; reverse, 5
 
9
 
 CAGTGTGAGCCAGGATATAG 3
 
9
 
).
Oligonucleotides were synthesized by Operon Technologies.
Competitive RT-PCR was carried out as previously described
(13). In brief, equivalent amounts of cDNA from sorted DCs
were added to each PCR reaction tube. Serial dilutions (total of
10 fourfold dilutions) of known amounts of competitive plasmid
pMCQ (provided by Dr. David Shire, Sanofi Recherche, Mont-
pellier, France) were added to the reaction tubes containing target
cDNA. The competitive plasmid DNA contained the same primer
templates as the target cDNA, and served as an internal standard.
PCR was carried out for 35 cycles as described above and the
products were analyzed on 1% agarose gels. The quantity of the
target cDNA template for TGF-
 
b
 
 and 
 
b
 
2m was determined by
the number of competitive plasmid molecules present in the lane
in which the band intensities of the target cDNA and the com-
petitor plasmid DNA are equivalent. The 
 
b
 
2m ratio was calcu-
lated as (No. of molecules of TGF-
 
b
 
 template in cDNA) / (No.
of molecules of 
 
b
 
2m template in cDNA) for each cDNA sample.
 
Antibodies.
 
Purified monoclonal rat anti–mouse IL-10
(JES5-16E3), hamster anti–mouse CD3
 
e
 
 (145-2C11), and hamster
anti–mouse CD28 (37.51) were purchased from PharMingen.
Monoclonal anti–TGF-
 
b
 
 antibody was purchased from Genzyme
Corp. For staining of epithelial cells, FITC-conjugated anti–pan
cytokeratin antibody (PCK-26) was purchased from Sigma
Chemical Co. Surface phenotype of DCs was analyzed with anti-
CD11c (HL3), anti-CD80 (16-10A1), anti-CD86 (GL1), anti-
CD11b (M1/70), anti-CD8
 
a
 
 (53-6.7), anti-CD45R (RA3-6B2),
anti–I-A
 
d
 
 (AMS-32.1), anti-DEC205 (NLDC-145), anti–ICAM-1
(3E2), anti–ICAM-2 (3C4), and anti-CD40 (HM-43). Naive T
cells from OVA TCR transgenic mice were stained with anti-
CD4–FITC (GK1.5) and anti-LECAM-1–PE (MEL-14). Before
staining, Fc receptors (Fc
 
g
 
RIII/II) were blocked using anti–mouse
CD16/CD32 (2.4G2). The antibodies used for DC and T cell
surface markers were purchased from PharMingen, except for
NLDC-145, which was purified from hybridoma obtained from
the American Type Culture Collection (HB290). Isotype-matched
controls used for staining DCs or in cytokine neutralization stud-
ies include mouse IgG1, 
 
k
 
 (107.3), rat IgG2a, 
 
k
 
 (R35-95), rat
IgG2b, 
 
k
 
 
 
(R35-38 or A95-1), rat IgG1, 
 
k
 
 (R3-34), hamster IgG
(G235-2356), and hamster IgM (G235-1), all of which were pur-
chased from PharMingen.
 
Preparation of DCs.
 
DCs were prepared from SP and PP of 
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naive 6–10-wk-old mice in parallel. PP were treated with media
containing dithiothreitol 145 
 
m
 
g/ml (Sigma Chemical Co.), 25 mM
Hepes (Biofluids Inc.), 10% FCS (Biofluids Inc.), and 5 mM EDTA
(Biofluids Inc.) in HBSS for 90 min at 37
 
8
 
C to remove epithelial
cells, and were washed extensively with HBSS. Both SP and PP
were digested with collagenase D (400 U/ml; Boehringer Mann-
heim) and DNase (15 
 
m
 
g/ml; Boehringer Mannheim), and incu-
bated in the presence of 5 mM EDTA at 37
 
8
 
C for 5 min. Single
cell suspension was prepared and cells were incubated with anti–
mouse CD11c-coated magnetic beads (Miltenyi Biotech) and se-
lected on MACS separation columns. Cells selected on the basis
of CD11c expression were then stained with PE-labeled anti-
CD11c antibody and FITC-labeled anti-B220 antibody.
CD11c
 
1
 
/B220
 
2
 
 cells were isolated by flow cytometric sorting
performed on a FACStar™ sorter (Becton Dickinson). Sorted
DCs were routinely 98–100% positive for CD11c. The sorted
population was rigorously screened for contamination by B and
T lymphocytes by performing RT-PCR on RNA derived from
sorted DCs using specific primer pairs for CD19 and CD3
 
e
 
, re-
spectively, using 35 cycles. Neither PP nor SP DC–sorted popu-
lations contained macrophage contamination because CD11c
 
2
 
/lo
 
macrophages are excluded by sorting cells that expressed only
high levels of CD11c (14).
 
Mixed Lymphocyte Reaction.
 
Allogeneic T cells were prepared
from SP of B10.A mice by negative selection using T cell enrich-
ment columns (R&D Systems). T cells (H-2
 
k
 
) at 10
 
5
 
 cells per well
were mixed with flow cytometrically sorted pure DCs from
BALB/c (H-2
 
d
 
) mice at various concentrations in 96-well micro-
titer plates for 48 h. Proliferation was measured by [
 
3
 
H]thymidine
incorporation during the last 8 h of incubation.
 
Preparation of TCR Transgenic T Cells.
 
SP T cells from DO11.10
OVA TCR transgenic mice or PCC TCR transgenic mice were
prepared by negative selection on T cell enrichment columns
(R&D Systems) according to the manufacturer’s instruction.
Since the PCC TCR transgenic mice contained no other lym-
phocytes (RAG2
 
2/2
 
), T cell–enriched column fraction (90%
CD3
 
1
 
) was used directly for DC–T cell cultures. From OVA
TCR transgenic mice, T cells were first enriched by negative se-
lection as above, followed by isolation of CD4
 
1
 
/MEL14
 
1
 
 T cells
by flow cytometric sorting using FITC-labeled anti-CD4 and
PE-labeled anti–LECAM-1 antibodies. Sorted T cell populations
were typically 99% positive for the two markers.
 
Stimulation of TCR Transgenic T Cells by DCs.
 
In vitro T cell
differentiation assays were performed according to previously es-
tablished methods (15). In brief, primary stimulation cultures
were established by coincubation of purified T cells (5 
 
3
 
 10
 
4
 
 cells
per well) and sorted CD11c
 
1
 
/B220
 
2
 
 DCs from SP or PP (5 
 
3
 
 10
 
3
 
cells per well) pulsed with the corresponding peptide (3 
 
m
 
M), and
1 ng/ml recombinant human IL-2 (Genzyme Corp.) in a 96-well
plate at 200 
 
m
 
l/well. In some cultures 20 
 
m
 
g/ml of a neutralizing
anticytokine antibody or isotype control antibody was added. Af-
ter 48 h, cells were transferred to 24-well plates and allowed to ex-
pand for 3–4 d in fresh medium without additional cytokines or
antibodies. T cells were then washed and 2 
 
3
 
 10
 
5
 
 cells were plated
on 96-well microtiter plates coated with anti-CD3
 
e
 
 (10 
 
m
 
g/ml) in
the presence of soluble anti-CD28 antibody (1 
 
m
 
g/well). Super-
natants from restimulated T cells were collected for detection of
IL-4 at 24 h and IL-10 and IFN-
 
g
 
 were collected at 48 h. Prolif-
eration of T cells was assayed by incorporation of [
 
3
 
H]thymidine
during the final 8 h of a 48-h incubation.
 
Stimulation of DCs by CD40L Trimer.
 
FACS
 
®
 
-purified CD11c
 
1
 
/
B220
 
2
 
 DCs (10
 
5
 
 per well) were incubated overnight in the pres-
ence of recombinant murine CD40L trimer (10 
 
m
 
g/ml; Immu-
nex Corp.) in a total volume of 200 
 
m
 
l per well of 96-well micro-
titer plate. Supernatants were collected and IL-10 and IL-12 p40
levels were measured by ELISA.
 
Measurement of Cytokine Production.
 
IL-10 and IFN-
 
g
 
 secre-
tion was assayed by a specific sandwich ELISA using antibody
pairs according to the manufacturer’s instructions (PharMingen).
The lower limit of detection was 10 pg/ml for IL-10 and 50 pg/ml
for IFN-
 
g. IL-4 was measured using a sandwich ELISA kit from
Endogen. The lower limit of sensitivity for IL-4 ELISA was 10
pg/ml. IL-12 p40 was measured using the OptEIA™ set (Phar-
Mingen), which had a lower limit of detection at 30 pg/ml.
Statistical Analysis. Normally distributed continuous variable
comparisons were done using Student’s t test.
Results
Phenotypic Analysis of Freshly Isolated DCs from PP and SP.
In our previous study, we identified distinct subsets of DCs
in murine PP by immunohistochemical analysis (11). When
DCs were isolated from murine PP by transient plastic ad-
herence, a technique that requires overnight culture at
378C, we found that their capacity to process and present
soluble antigens was equivalent to that of DCs similarly de-
rived from the SP. In addition, we found that the surface
expression of DC markers as well as costimulatory mole-
cules were largely similar between transiently adherent SP
and PP DCs. The one exception to this rule was the ex-
pression of MHC class II, which was found to be 5–10-fold
higher on PP DCs. However, since it is known that over-
night culture of DCs can result in their differentiation, cells
isolated by this technique do not necessarily reflect the state
of DC differentiation in vivo. To overcome this problem,
we developed techniques to study freshly isolated DCs. This
allowed us to more accurately compare the phenotype and
function of DCs from PP and SP.
In initial experiments, we analyzed the expression of T
and B cell markers on DC-enriched populations positively
selected from PP and SP on the basis of their expression of
CD11c, a well-established marker for DCs in mice. As
shown in Fig. 1 A, we found that a significant proportion
of anti-CD11c magnetic bead–selected cells from both PP
(30%) and SP (9%) expressed B220, whereas cells express-
ing CD3 were undetectable (data not shown). We next de-
termined that at least some of these B2201 cells were in-
deed B cells, since RT-PCR analysis of flow cytometrically
sorted CD11c1/B2201 cells demonstrated the presence of
mRNA for CD19 (Fig. 1 B). In contrast, we found that the
sorted CD11c1/B2202 cell population contained no de-
tectable mRNA for CD19, nor did it contain detectable
mRNA for CD3 (Fig. 1 B). Thus, to exclude B cell con-
tamination from DC preparations, magnetically sorted
CD11c1 cells were purified by flow cytometric sorting on
the basis of CD11c1/B2202 expression (Fig. 1 A) and were
routinely screened by RT-PCR for expression of B (CD19)
and T cell (CD3) markers. Moreover, neither PP DC or SP
DC sorted populations contained macrophage contamina-
tion since CD11c2/lo macrophages are excluded by sorting
cells that expressed only high levels of CD11c (14). Finally,232 Distinct T Cell Priming by Spleen and Peyer’s Patch Dendritic Cells
since PP cell preparations often contain large numbers of
intestinal epithelial cells, it was necessary to exclude con-
tamination of the sorted DCs by epithelial cells. Although
PP were pretreated with dithiothreitol- and EDTA-contain-
ing media to remove epithelial cells, it was theoretically
possible that any remaining epithelial cells could be selected
by nonspecific binding to the anti-CD11c antibody-coupled
magnetic beads. To exclude this possibility, sorted CD11c1/
B2202 cells were stained with an anti–pan cytokeratin anti-
body, which recognizes a broad spectrum of cytokeratin
proteins expressed by epithelial cells. As shown in Fig. 1 C,
cytokeratin-specific staining was not observed in DCs iso-
lated from either PP or SP, whereas freshly isolated intesti-
nal epithelial cells were strongly stained by the same anti-
body. Taken together, these initial experiments confirmed
that the CD11c1/B2202 populations of cells isolated by
the technique used here were highly purified DCs.
We next analyzed the expression of DC surface antigens
on CD11c1/B2202 cells from PP and SP. As shown in Fig.
2, we found that freshly isolated CD11c1/B2202 PP DCs
expressed 5–10-fold higher levels of MHC class II antigen
compared with SP DCs, as we had previously observed
with overnight cultured transiently adherent DCs (11). Next,
we analyzed the expression of lymphoid DC markers. Lym-
phoid DCs, which are thought to be involved in the inhi-
bition of peripheral T cell responses, have been shown to
express the a chain dimer of CD8 and high levels of Fas
ligand (16). Moreover, in some reports CD8a chain ex-
pression by DCs correlates strongly with expression of
DEC-205, suggesting that DEC-205 may be an additional
or independent marker of lymphoid-derived DCs (17). As
it has been shown that lymphoid DCs are highly adherent
cells that are only released from tissues and adherent T cells
by treatment with EDTA (17), we routinely incorporated
treatment with EDTA before magnetic bead isolation, as
previously described by Vremec et al. (18), to ensure re-
lease of all DC subsets. As shown in Fig. 2, when CD11c1/
Figure 1. Phenotypic analysis of sorted DC populations from SP and
PP. (A) Cells from PP or SP were isolated using magnetic beads as de-
scribed in Materials and Methods, and were dual stained with the FITC-
conjugated anti-B220 and PE-conjugated anti-CD11c antibodies. Cells
that subsequently were sorted by FACS® and used for T cell stimulation
are indicated by the enclosed square (CD11c1/B2202). (B) RT-PCR
analysis of B and T cell contamination in sorted DC populations. Mag-
netically selected DCs from SP and PP were further purified by flow cy-
tometric sorting into either CD11c1/B2202 or CD11c1/B2201 cells.
Total RNA was extracted from sorted DCs and analyzed by RT-PCR
for expression of B (CD19) and T (CD3) cell markers. RT-PCR of b2m
was included as a positive control for mRNA in each sample. An RT-
PCR profile of total PP tissue was included to indicate that B and T cells
were present in the starting population (right). (C) Exclusion of epithelial
cells from sorted DC populations. CD11c1/B2202 cells from SP and PP
were stained for the pan-epithelial cell marker, cytokeratin. In parallel,
freshly isolated intestinal epithelial cells were stained with the same anti-
body (dotted line) as a positive control.
Figure 2. Surface phenotype analysis of sorted DC populations from
SP and PP. Sorted CD11c1/B2202 DCs from SP or PP were analyzed
for expression of various surface molecules. The results are shown as his-
tograms with fluorescence intensity on the x-axis and cell number on the
y-axis. The thin lines represent staining of SP DCs, and the thick lines
staining of PP DCs. Isotype-matched control is indicated for each anti-
body set with a dotted line. The data depicted here represents four inde-
pendent experiments producing similar results.233 Iwasaki and Kelsall
B2202 DCs from PP and SP were analyzed, comparable
percentages of cells were found to express CD8a and
DEC-205 (Fig. 2), although Fas ligand expression was un-
detectable in either population (data not shown). In addi-
tion, we stained for CD11b, a b2 integrin that has been as-
sociated with DCs and which may be derived from a
myeloid, as opposed to lymphoid, precursor. Although we
could discern a clear population of CD11bhi cells from both
PP and SP DCs, the majority of cells from both groups ex-
pressed moderate levels of CD11b. Finally, we determined
the expression of costimulatory molecules and adhesion
molecules, as these may influence T cell differentiation.
We found that CD80 and CD86, as well as CD40, were
expressed at low to moderate, but equivalent, levels on
freshly isolated SP and PP DCs. Moreover, high levels of
adhesion molecule ICAM-1 were expressed by both SP
and PP DCs, whereas ICAM-2 expression was negligible
in both DC populations. Therefore, with the exception of
MHC class II antigen, the DCs freshly isolated from PP and
SP appeared to have a similar surface phenotype.
Highly Purified Fresh CD11c1 DCs from PP Are More Po-
tent Stimulators of Allogeneic T Cells. We next determined
whether PP and SP DCs also had a similar capacity to in-
duce primary T cell responses by measuring the ability of
freshly isolated CD11c1/B2202 cells to stimulate allogeneic
T cells in vitro. Varying numbers of BALB/c (H-2d) DCs
were cultured with T cells purified from B10.A (H-2k) mice.
Proliferation of allogeneic T cells was then determined by
[3H]thymidine incorporation. As shown in Fig. 3, we found
that PP DCs were much more potent for stimulating allo-
geneic T cells than were SP DCs. We next determined
whether this enhanced ability to induce primary T cell pro-
liferation could be restricted to a particular MHC back-
ground of the stimulating or responding populations. We
found that PP DCs were consistently more potent stimula-
tors of allogeneic T cell proliferation compared with SP
DCs in all the mouse strain combinations that have been
tested to date [B10.A (H-2k) DCs 1 C57B/6 (H-2b) T
cells, B10.A DCs 1 BALB/c T cells, BALB/c DCs 1
C57B/6 (H-2b) T cells] (data not shown).
PP DCs Prime OVA TCR Transgenic T Cells (BALB/c) to
Produce Th2 Cytokines, Whereas SP DCs Prime only for a Th1
Response. We next determined whether PP and SP DCs
had different capacities for inducing Th cell differentiation.
This was of particular interest because two unique func-
tions of the mucosal immune system, production of secre-
tory IgA and suppression of responses to ubiquitous envi-
ronmental antigens, are both Th cell–dependent processes.
Specifically, optimal IgA-B cell differentiation (19–21), as
well as the effector functions of regulatory T cells induced
after low dose antigen feeding (22, 23), have been shown
to depend on Th2 and Th3 (TGF-b) cytokines. Moreover,
B cell switching to IgA requires a CD40L signal from acti-
vated T cells (21). Thus, to further characterize the antigen-
presenting capacity of DCs isolated from these tissues,
FACS®-sorted CD11c1/B2202 cells from BALB/c SP and
PP were used to stimulate naive CD41/LECAM-1hi FACS®-
sorted T cells from OVA TCR transgenic mice in the pres-
ence of OVA 323–339 peptide. As indicated in Fig. 4 A,
PP DCs induced two- to threefold higher expansion of na-
ive T cells than did SP DC during primary culture, consis-
tent with the enhanced capacity to drive allogeneic T cell
proliferation that was noted above. Interestingly, as shown
in Fig. 4 B, we also found that secondary stimulation of PP
DC–primed T cells with plate-bound anti-CD3e and solu-
ble anti-CD28 in the absence of APCs consistently resulted
in 10-fold higher proliferation when compared with SP
DC–primed T cells. Although the reasons for this en-
hanced proliferation during secondary culture are not yet
clear, this finding suggests that T cells initially stimulated
with PP DCs are fundamentally different than those stimu-
lated with SP DCs.
We next determined the cytokine secretion pattern of
OVA TCR transgenic T cells primed with PP or SP DCs
and restimulated with anti-CD3 and anti-CD28. As shown
in Fig. 5, T cells primed with PP DCs secreted fivefold
higher levels of IL-4 than SP DC–primed T cells. Most
strikingly, PP DCs also primed T cells to secrete IL-10,
whereas IL-10 secretion was minimal from T cells stimu-
lated with SP DCs. In contrast, IFN-g secretion was two-
to threefold higher in T cells primed with SP DCs than
with PP DCs, although both T cell populations produced
substantial amounts of IFN-g. This reduction in IFN-g
production by PP DC–stimulated T cells was partially or
fully reversed by addition of a neutralizing anti–TGF-b an-
tibody and anti-IL-10 antibody, respectively (Fig. 5 D).
The addition of anti–TGF-b antibody to PP DC–T cell
culture also enhanced secretion of IL-4 and IL-10, but not
in SP DC–T cell culture, suggesting that either PP DCs
themselves secrete TGF-b, or that they induce T cells to
secrete TGF-b that suppresses the production of IL-4,
IFN-g, and IL-10. Furthermore, in an effort to evaluate
the overall capacity of DCs to differentiate and proliferate
Figure 3. DCs from PP are more potent stimulators of allogeneic T
cell proliferation than are those from SP. Mixed lymphocyte reaction was
carried out with varying numbers of purified BALB/c DCs (H-2d) and
105 T cells from B10.A (H-2k) mice per well in 96-well microtiter plates.
Proliferation was measured by [3H]thymidine uptake during the last 8 h
of a 48-h culture. Results are represented as the mean cpm of triplicate
cultures on the y-axis, with the number of DCs per well on the x-axis.
Similar results were obtained in three separate experiments conducted in
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T cells, we normalized the levels of cytokines produced by
T cells during the secondary stimulation to the expansion
of T cells during the priming culture (Table I). By analyz-
ing the data in this fashion, we determined that the overall
difference in secretion of IL-4 and IL-10 between PP DC–
or SP DC–primed T cells was even greater than we had
previously determined (due to higher expansion of T cells
by PP DCs). Moreover, the observed increase in IFN-g se-
cretion by neutralizing IL-10 was considerable only from T
cells stimulated with PP DCs (fourfold higher than isotype
control).
Splenic DCs Prime PCC TCR Transgenic T Cells (B10.A)
to Produce Higher Levels of IFN-g. It is known that the de-
fault cytokine secretion pattern of T cells under a neutral
priming condition is determined by the genetic back-
ground of mice from which the T cells are isolated (24). The
OVA TCR transgenic mice we used are of the BALB/c
background, in which the T cells are predisposed towards
the Th2 cytokine production. To determine whether the
Th cell phenotype differences induced with PP and SP DCs
that were observed in our OVA TCR transgenic system
priming also applied to a Th1-predisposed strain, we car-
ried out the same set of experiments in the B10.A (Th1)
background. T cells from PCC TCR transgenic mice
(B10.A) were stimulated with purified, sorted B10.A
CD11c1/B2202 DCs from PP or SP. Cytokine production
from T cells during secondary stimulation with plate-
bound anti-CD3e and soluble anti-CD28 was assessed. It is
evident from Fig. 6 that three to fourfold higher IFN-g se-
cretion was induced in SP DC–primed T cells compared
with PP DC–primed T cells, as in the case of BALB/c
mice (Fig. 5). In contrast, no IL-10 or IL-4 was detected in
secondary cultures of T cells initially primed with PP or SP
DCs. Thus, although PP DCs induce Th2 cytokines in
BALB/c (Th2) mice, they are not capable of overcoming
the Th1 bias of B10.A mice, despite the fact that PP DCs
Figure 4. PP DCs induced higher expansion
of OVA TCR transgenic T cells during pri-
mary and secondary culture than did SP DCs.
(A) Naive CD41/MEL141 FACS®-sorted
OVA TCR transgenic T cells (5 3 104 per
well) were coincubated with CD11c1 DCs
sorted from PP or SP (5 3 103 per well) for
5–6 d in the presence of blocking antibodies
against TGF-b, IL-10, or isotype control anti-
body. Live cells were counted using hemacy-
tometer by exclusion of dead cells with Trypan
blue staining. The figure depicts the factor by
which the number of T cells multiplied during
priming by either PP or SP DCs on the y-axis.
(B) OVA TCR transgenic T cells primed with DCs as described in A were restimulated with plate-bound anti-CD3e and soluble anti-CD28 antibodies for
48 h. Proliferation of T cells was determined by incorporation of [3H]thymidine, which was added to the culture wells during the last 8 h of incubation. Data
is representative of four separate experiments producing similar results.
Figure 5. Cytokine produc-
tion by OVA TCR transgenic T
cells during secondary stimula-
tion. Naive CD41/MEL141
FACS®-sorted OVA TCR trans-
genic T cells were stimulated
with purified CD11c1 DCs iso-
lated from SP (A, B, and C) or
PP (D, E, and F) in the presence
of blocking antibodies against
TGF-b, IL-10, or isotype control
antibody for 5–6 d. T cells were
restimulated with plate-bound
anti-CD3e and soluble anti-
CD28 antibodies for up to 48 h.
Supernatants were harvested and
IFN-g (A and D), IL-4 (B and
E), and IL-10 (C and F) levels
were measured by ELISA at 24
(IL-4) or 48 h (IFN-g and IL-10).
The P values for cytokines se-
creted in the presence or absence
of neutralizing antibody in the
priming cultures are indicated
with value labels or with an as-
terisk if P . 0.05. This experi-
ment was repeated four times
producing similar cytokine secre-
tion patterns.235 Iwasaki and Kelsall
were less capable of inducing IFN-g–secreting cells. Next,
the role of TGF-b and IL-10 in T cell priming was as-
sessed. As shown in Fig. 5 (BALB/c), IFN-g secretion was
enhanced from PP DC– but not from SP DC–primed T
cells derived from B10.A mice in the presence of neutraliz-
ing antibody against either TGF-b or IL-10 in priming cul-
ture (Fig. 6). Taken together, in two separate strains of
mice, (a) PP DCs were found to prime T cells to produce
lower levels of IFN-g compared with SP DC–primed T
cells, and (b) both TGF-b and IL-10 suppressed IFN-g pro-
duction in PP DC–T cell, but not SP DC–T cell, cocul-
ture.
Detection of TGF-b Secreted by PP and SP DCs. Because
the presence of neutralizing antibody against TGF-b dur-
ing the priming culture dramatically increased the secretion
of cytokines by T cells stimulated with PP DCs, we rea-
soned that either TGF-b is being secreted by PP DCs and/or
that PP DCs induce T cells to secrete TGF-b. To address
this issue, we attempted to measure TGF-b secretion by
ELISA from T cells alone (in the secondary T cell stimula-
tion culture) or DC alone (in the DC stimulation culture).
To mimic DC–T cell interaction, DCs were stimulated with
a soluble, trimerized, recombinant form of murine CD40L,
a molecule normally expressed on activated T cells. We
could not detect secretion of TGF-b above background
levels (.200 pg/ml) after stimulation of either T cells or
DCs in serum-containing media. We also failed to detect
TGF-b production by T cells or DCs in serum-free media,
which was probably due to the poor viability of cells in
these conditions. In the absence of serum, secretion of
other cytokines such as IL-10 was also minimal (data not
shown). However, when the expression of mRNA for
TGF-b was assessed from freshly isolated DCs, much
higher levels of TGF-b message was found in PP DCs
compared with SP DCs in both strains of mice (Fig. 7).
Moreover, there was no detectable mRNA for TGF-b in
SP DCs in the B10.A mice even in the absence of compet-
itive plasmid DNA in the PCR reaction (Fig. 7 B).
CD40-mediated Stimulation of PP DCs but not SP DCs In-
duces Secretion of IL-10. One possible mechanism underly-
ing the distinct cytokine production patterns induced by
stimulation of T cells with PP DCs (Th2) and SP DCs
(Th1) may be that these DCs secrete discrete sets of cyto-
kines upon activation by T cells. To address this possibility,
cytokine production by purified DCs from BALB/c and
B10.A mice in the absence of T cells was assessed. After
overnight incubation of sorted CD11c1/B2202 DCs with
CD40L trimer, supernatants were assessed for the presence
of IL-12 and IL-10. As shown in Fig. 8, we found that PP
DCs secreted high levels of IL-10, whereas no detectable
IL-10 secretion was observed from SP DCs under the same
condition in both strains of mice. In contrast, similar levels
Table I. Cytokine Secretion from OVA TCR Transgenic T Cells Primed with Either PP or SP DCs Normalized to T Cell Expansion
Priming by: Antibody IFN-g IL-4 IL-10
ng/ml ng/ml ng/ml
PP DCs Isotype 229.09 6 10.10 76.61 6 13.58 16.54 6 0.78
Anti–TGF-b 367.01 6 22.99* 147.59 6 24.33* 45.12 6 1.80‡
Anti–IL-10 956.42 6 19.16‡ 62.10 6 10.74 21.43 6 2.79
SP DCs Isotype 313.30 6 14.85 10.59 6 1.81 0.23 6 0.02
Anti–TGF-b 95.66 6 3.86‡ 4.47 6 1.24* 0.05 6 0.01*
Anti–IL-10 138.67 6 2.58‡ 20.15 6 0.10‡ 0.03 6 0.02*
The amount of cytokine secreted during the secondary stimulation culture in Fig. 5 was normalized to T cell expansion during the priming culture
(Fig. 4) by the following formula:
*P , 0.05.
‡P , 0.005.
Normalized cytokine Cytokine level in secondary culture   total No. of cells after priming culture ´
No. of T cells in the secondary culture
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- =
Figure 6. SP DCs induce higher IFN-g secretion by PCC TCR trans-
genic T cells than do PP DCs. Naive PCC TCR transgenic T cells were
stimulated with purified CD11c1 DCs isolated from SP (A) or PP (B) in
the presence of blocking antibodies against TGF-b, IL-10, or isotype
control antibody for 5 d. T cells were restimulated with plate-bound anti-
CD3e and soluble anti-CD28 antibodies for up to 48 h. Supernatants
were harvested and IFN-g level was measured by ELISA at 48 h. The
P values for cytokines secreted in the presence or absence of neutralizing
antibody in the priming cultures are indicated either as a number or an as-
terisk if P . 0.05. The same experiment was repeated three times pro-
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of IL-12 p40 were detected from both SP and PP DC cul-
ture supernatants in BALB/c mice, whereas higher levels of
IL-12 p40 was detected from SP than PP DCs in B10.A
background. Levels of IL-12 p70 were below the level of
detection by ELISA (z30 pg/ml) in supernatants from
both PP and SP DCs (data not shown).
Discussion
To study physiologically relevant DC populations from
two distinct lymphoid tissues, namely PP and SP, we used
freshly isolated DCs purified on the basis of their surface
expression of CD11c. These highly purified DC popula-
tions devoid of B cells, T cells, and macrophages from PP
and SP were strikingly different in their ability to stimulate
T cells in vitro. First, PP DCs were much more potent in
stimulating proliferation of both allogeneic (Fig. 3) and an-
tigen-specific (Fig. 4) T cells compared with SP DCs. A
possible explanation for these findings is that PP DCs were
found to express 5–10-fold higher levels of MHC class II
antigens than SP DCs (Fig. 2) and thus on a per cell basis
are likely to provide a more potent signal to the responding
T cell by engaging more TCRs. The enhanced ability to
induce proliferation by PP DCs also suggested that these
cells may be intrinsically more “mature” in their pheno-
type, since maturation has been shown to correlate with
enhanced expression of MHC class II, as well as costimula-
tory molecules that could affect T cell proliferation. How-
ever, we found that CD80, CD86, and CD40 expression
was low to modest, and similar for PP and SP DC popula-
tions. In addition, we found that levels of the adhesion
molecules ICAM-1 and ICAM-2 were also similarly ex-
pressed by PP and SP DCs (Fig. 2). Thus, it appeared that
neither population of cells was fully mature or differenti-
ated, and that higher expression of these costimulatory and
adhesion molecules could not explain the enhanced ability
of PP DCs to induce primary T cell proliferation. The
findings presented here are consistent with prior studies by
Ruedl et al. that demonstrated that freshly isolated CD11c1
cells from PP are functionally immature (25). Thus, it was
shown that upon overnight culture in the presence of ei-
ther GM-CSF and TNF-a or anti-CD40 antibody, freshly
isolated PP DCs matured as determined by their higher
levels of expression of MHC class II, CD80, and CD86,
and their loss of the ability to process intact antigens (25).
Whether PP DCs express as yet unidentified costimulatory
molecules or soluble factors responsible for the induction of
increased T cell proliferation remains to be determined.
We next determined whether the tissue specificity of DCs
influences the type of Th cell responses induced during anti-
gen-specific stimulation. For these studies, we primed naive
CD41 T cells from OVA TCR transgenic mice in vitro with
freshly isolated CD11c1/B2202 DCs from PP or SP, and
determined the phenotype of the primed cells by measur-
ing cytokine production after secondary stimulation of T
cells with anti-CD3 and anti-CD28 antibodies. Interest-
ingly, we found that PP but not SP DCs primed T cells for
the production of IL-4 and particularly IL-10. In addition,
the level of IFN-g produced by T cells primed with SP
DCs was significantly higher than that produced by T cells
primed with PP DCs. Furthermore, when cytokine produc-
tion was normalized to T cell expansion, we found even
greater differences in the amounts of cytokines produced
by T cells primed with either PP or SP DCs.
In an effort to investigate the mechanisms underlying the
particular ability of PP DCs to stimulate Th2 cytokine re-
sponses, we next determined whether TGF-b was prefer-
entially expressed by PP DCs or generated in PP DC–T
cell cultures, and whether this cytokine was affecting the
Figure 7. Expression of TGF-b by freshly isolated PP DCs. cDNA sam-
ples prepared from freshly isolated PP and SP DCs from BALB/c (A) or
B10.A (B) mice were analyzed by competitive RT-PCR for the expression
of TGF-b and a control marker, b2m, as described in Materials and Meth-
ods. The ratios of TGF-b mRNA level to b2m mRNA level derived from
the same cDNA sample are depicted on the y-axis as the mean values of at
least three separate experiments 6 SEM. The number of separate experi-
ments done for each DC population are indicated in parentheses.
Figure 8. IL-10 is produced only by PP DCs after CD40L trimer stimu-
lation, whereas similar levels of IL-12 p40 is detected from both DC types.
FACS®-purified CD11c1 DCs (105 per well) from BALB/c (A and B) or
B10.A (C and D) mice were incubated overnight in the presence of
CD40L trimer (10 mg/ml). Supernatants were collected and IL-10 (A and
C) and IL-12 p40 (B and D) levels were measured by ELISA. Each column
is representative of four (A and B) or two (C and D) separate experiments.237 Iwasaki and Kelsall
differentiation of T cells into a Th2 pathway. This possibil-
ity was based on prior studies suggesting a role for TGF-b
in directing Th2 responses in murine infection with Leish-
mania (26) as well as in driving Th2 immune deviation seen
after antigen administration to the anterior chamber of the
eye (27). We initially determined the ability of neutralizing
anti–TGF-b antibodies added to the primary culture to al-
ter the T cell phenotype induced by PP and SP DCs. Inter-
estingly, neutralization of TGF-b resulted in increased lev-
els of IFN-g, IL-4, and IL-10 production by PP DC–, but
not by SP DC–, primed T cells (Fig. 5). This increase in
cytokine production did not appear to be due to enhanced
expansion of cytokine-producing T cells, as [3H]thymidine
incorporation during secondary stimulation was identical in
cells treated and untreated with blocking antibodies (Fig. 4).
We extended our finding of the inhibitory effects of TGF-b
on IFN-g production by PP DC–primed T cells to another
TCR transgenic system of different genetic background
(B10.A), confirming that the effect is not a BALB/c strain–
dependent phenomenon (Fig. 6). Although the role of
TGF-b in suppressing IFN-g secretion has been well doc-
umented (26, 28), its effect in modulating Th2 cytokine
secretion from T cells is at best controversial. Our obser-
vations argue that TGF-b in the priming culture was sup-
pressive to the induction of IFN-g– as well as IL-4– and
IL-10–producing T cells. Although there is evidence that
the presence of TGF-b can suppress IL-4 and IL-5 secre-
tion from purified T cells activated with anti-CD3 (29),
further investigation is required to clarify the direct effect of
TGF-b in the differentiation of Th2 cells.
The source of TGF-b responsible for the observed sup-
pression was either PP DCs and/or T cells primed with PP
DCs. To address this possibility, we attempted to directly
measure TGF-b production from freshly isolated PP and SP
DCs. Although we were unable to detect TGF-b by ELISA
from overnight cultures of freshly isolated DCs stimulated
with CD40L, we did find that the level of expression of
TGF-b mRNA was found to be much higher in PP DCs
compared with SP DCs in both strains of mice (Fig. 7).
Moreover, there was no detectable mRNA for TGF-b in
SP DCs in the B10.A mice. Although TGF-b mRNA lev-
els do not always correlate with the level of protein secre-
tion (30, 31), our data suggested that only PP DCs had
constitutive TGF-b mRNA expression, and that the level
of TGF-b produced is able to suppress both Th1 and Th2
cytokine secretion by T cells in the PP DC–T cell, but not
SP DC–T cell, coculture. In PP, the presence of high levels
of TGF-b, in combination with the Th2-inducing pheno-
type of PP DCs, may play an important role in regulating
the local Th cell responses. In other words, the cytokine
environment in PP may modify DCs as well as T cells to
ensure that unwanted Th1 responses towards noninfectious
materials such as food antigens are prevented.
We next determined the role of IL-10 in T cell differen-
tiation by PP and SP DCs. We found that the addition of a
neutralizing anti–IL-10 during priming cultures resulted in
significantly enhanced IFN-g secretion from the T cells
primed with PP DCs, almost to the levels secreted by T
cells stimulated with SP DCs (Fig. 5). This result is consis-
tent with IL-10 being a potent inhibitor of Th1 develop-
ment (32). It was also found that T cells primed by SP DCs
in the presence of anti–IL-10 antibody secreted higher lev-
els of IFN-g. However, when cytokine secretion was nor-
malized to the expansion of T cells during the priming cul-
ture, we found considerable increase in IFN-g only from
PP DC–primed T cells in the presence of anti–IL-10 anti-
body (Table I). Thus, significant suppression of IFN-g was
mediated by IL-10 present in the PP DC–T coculture. We
next explored whether IL-10 produced directly from PP
DCs could be responsible for the differentiation of T cells
that secrete low levels of IFN-g and high levels of IL-4 and
IL-10. When IL-10 production by purified DCs was as-
sessed upon stimulation with CD40L trimer, we found that
PP but not SP DCs secrete high levels of IL-10. Therefore,
the exclusive ability of PP DCs to generate IL-10–secreting
T cells may at least be partially due to the production of IL-10
by PP DCs themselves. However, the fact that blocking
IL-10 during T cell priming by PP DCs only partially con-
verts T cell phenotype towards Th1 suggests that other fac-
tors might be involved in the Th2 development by PP DCs.
One final possible explanation for why PP and not SP
DCs induce Th2 differentiation is related to the enhanced
ability of PP DCs to stimulate T cell proliferation. Recently,
it has been shown that naive murine CD41 T cells have an
intrinsic program for the transcription of the IL-4 gene that
is directly related to the number of times the T cell divides.
Thus, it was shown that the expression of IL-4 begins to
occur after the third cell division, and that this expression is
independent of exogenous IL-4 signaling, as similar results
were found with T cells from STAT-6–deficient mice (33).
This suggests that the enhanced proliferation of T cells
stimulated by PP DCs may result in an intrinsic bias toward
Th2 development, which, when occurring in an environ-
ment that has low levels of IL-12 due to the production of
IL-10 by PP DCs, results in the selection or emergence of
T cells with a Th2 phenotype.
Taken together, the data presented here provide the first
demonstration of the ability of DCs from the murine PP to
preferentially induce the differentiation of CD41 T cells
into a Th2 pathway. Previous studies have suggested that
different APC types could direct Th responses to either
Th1 or Th2 (34–37). In addition, a recent study by Stum-
bles et al. suggested a similar Th2-inducing phenotype of
DCs derived from the rat airway mucosa (28). In that study,
repeated injections of OVA-pulsed rat respiratory tract DCs
lead to increasing levels of IgG1 but not IgG2b in the rats
known to be Th2- and Th1-dependent IgG subclasses, re-
spectively (38, 39). The data presented here supports the
claim that resting tissue-resident DCs at mucosal surfaces
have a unique ability to drive T cell responses towards the
Th2 pathway. Finally, it has been reported recently that
DCs that express the CD8a molecule (lymphoid-derived)
drive predominant Th1 responses and that DCs lacking the
CD8a molecule preferentially drive Th2 responses in vivo
(40, 41). Since we found that equivalent numbers of DCs
from SP and PP express CD8a, a difference in DCs popu-238 Distinct T Cell Priming by Spleen and Peyer’s Patch Dendritic Cells
lations, per se, cannot offer an explanation for the differences
in T cell differentiation shown here. We are currently inves-
tigating the potential differences in the functions of these
DC subsets between PP and SP.
The mechanism by which tissue-specific DCs influence
Th cell development after an oral antigenic challenge can
be speculated as follows. Intestinal antigens transported via
M cells are taken up by SED DCs, which migrate to the T
cell region and become IFR DCs. During migration, SED
DCs can undergo two distinct developmental pathways. If
the antigen encountered is a noninfectious food antigen,
the default pathway for IFR DCs is to generate Th2/Th3
responses. However, upon encounter with infectious agents,
maturation of DCs is triggered by interaction with some
components of the invading microorganism such as LPS
(42, 43). This maturation of DCs leads to secretion of high
levels of IL-12, which induces T cells to secrete IFN-g re-
sulting in Th1 responses. In support of this hypothesis,
IFN-g secretion by PP T cells has been observed after gas-
trointestinal infection with microorganisms known to stim-
ulate production of IL-12 by macrophages and DCs, such
as Salmonella typhimurium (3–6) and Toxoplasma gondii (7).
Efforts to test this hypothesis are currently underway by an-
alyzing the phenotype of PP DCs in vivo after oral delivery
of microbial stimuli. Such a default Th2/Th3 environment
in the intestinal tract may be indispensable because aberrant
Th1 induction in the intestine is strongly associated with
pathogenesis of inflammatory bowel diseases such as Crohn’s
disease (44).
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